CN Patent

CN114630666A — 减少施用磷酸二酯酶-4抑制剂的副作用的方法

Assigned to Alcutis Biotherapy Co ltd · Expires 2022-06-14 · 4y expired

What this patent protects

一种改变含有PDE‑4抑制剂(如罗氟司特)的药物制剂的PK谱的方法，以降低Cmax的尖峰。通过将PDE‑4抑制剂与一种或多种磷酸酯表面活性剂相结合后局部施用降低Cmax的尖峰。降低Cmax的尖峰将减少胃肠道副作用，并导致更好的患者依从性。

USPTO Abstract

一种改变含有PDE‑4抑制剂(如罗氟司特)的药物制剂的PK谱的方法，以降低Cmax的尖峰。通过将PDE‑4抑制剂与一种或多种磷酸酯表面活性剂相结合后局部施用降低Cmax的尖峰。降低Cmax的尖峰将减少胃肠道副作用，并导致更好的患者依从性。

Drugs covered by this patent

Patent Metadata

Patent number
CN114630666A
Jurisdiction
CN
Classification
—
Expires
2022-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Alcutis Biotherapy Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.